Lilly Just Announced Infectious Disease Deals Diversification
Eli Lilly is shaking up its growth plan by expanding beyond obesity with new infectious disease initiatives. This art...
Explore conversion timing for a two-earner couple, including tax impact, income thresholds, and optimal years to convert for long-term growth.
18,272 articlesEli Lilly is shaking up its growth plan by expanding beyond obesity with new infectious disease initiatives. This art...
A successful founder learns that financial freedom can come from rents, not more revenue. This story shows how to piv...
A small BTC sale by Strategy is not a capitulation. The firm says the move funds preferred stock distributions while ...
When a CEO sells stock, investors listen. This article breaks down what the Electronic Arts CEO's roughly $1 million ...
Occidental stock popped today as fourth-quarter results highlighted strong cash flow and favorable energy dynamics. T...
Salesforce is a powerhouse, but big questions remain about margins and AI-driven pricing. This piece explains why I’m...
The Ethereum Foundation has begun staking ETH as part of a new treasury plan, coinciding with sales from Ethereum co-...
As biotech investors digest Recursion's latest quarterly results, this Deep Dive breaks down what recursion (rxrx) 20...
Target unveiled a bold turnaround, but questions linger about what Target's Michael Fiddelke may be missing about eve...
A billionaire activist investor is stepping in with a bold move on Pinterest. This deep dive breaks down what this co...
Inflation is pushing shoppers to hunt for value, and Target is answering with a broad price-cut program on 3,000 item...
The (onon) 2026 earnings call offers critical clues about growth drivers, margin reset, and next steps for investors....